1. ReportLinker Data
  2. Sold Production of Antis…

Sold production of antisera, other immunological products and other blood fractions in Denmark climbs in 2017

Sold production of antisera, other immunological products and other blood fractions grew sharply by 41.9 percent compared to the previous year, according to adjusted numbers published by European Commission. Sold production of antisera, other immunological products and other blood fractions strongly climbed by 439 169.18 Euro, compared with the prior year when it declined by 31.75%. Denmark saw a decrease of 88.21% in sold production of antisera, other immunological products and other blood fractions over the past 6 years. Moreover, it has attained the average annual growth rate of 0.05% over the last 5 years with a slight overall drop since the start of observations. It averaged 3 143 867.7 Euro from 2012 to 2017 and it attained its all-time high of 12 616 575 Euro in 2012 and record low of 994 259 Euro in 2014.

Sold production of antisera, other immunological products and other blood fractions in Denmark climbs in 2017
Date Euro Variation
2017 1 487 361.18 41.9
2016 1 048 192.00 -31.75
2015 1 535 924.00 54.48
2014 994 259.00 -15.8
2013 1 180 895.00 -90.64
2012 12 616 575.00 N/A